NCT06127511

Brief Summary

A multi-school, two-arm parallel cluster-randomized controlled trial will be conducted in 200 healthy young adolescents from Barcelona (Spain) to evaluate the effect of peanut consumption on cognitive performance, weight management and inflammation. Schools willing to participate will be randomly assigned to either the intervention or the control group. After the recruitment, the participants will follow a peanut-free diet for two weeks. Both arms will receive a multidimensional educational intervention designed by the Gasol Foundation to promote healthy dietary habits based on Mediterranean diet recommendations, along with exercise performance, healthy sleeping habits and emotional knowledge. Half of the participants (intervention group) will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 29, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

1.4 years

First QC Date

October 31, 2023

Last Update Submit

March 31, 2025

Conditions

Keywords

peanutcognitiveinflammationweightadolescentobesitygut microbiotahealthy dietaryphysical activitysleepingbehaviour habitsMediterranean diet

Outcome Measures

Primary Outcomes (10)

  • Changes in the depression score in healthy young adolescents after a daily intake of peanuts.

    To measure depression score, the CDI Childhood Depression Inventory test will be used.

    Baseline and after 6 months

  • Changes in the ability to concentrate, selective attention and processing speed in healthy young adolescents after a daily intake of peanuts.

    To measure the ability to concentrate, selective attention and processing speed, the d2-R Attention Test (Revised) will be used.

    Baseline and after 6 months

  • Changes in assessment of interference and cognitive control in healthy young adolescents after a daily intake of peanuts.

    To measure the assessment of interference and cognitive control, the Stroop test will be used.

    Baseline and after 6 months

  • Changes in processing speed, attention span and working memory in healthy young adolescents after a daily intake of peanuts.

    To measure processing speed, attention span and working memory, the WISC-V Digits and Codes Subtest will be used.

    Baseline and after 6 months

  • Changes in attention and inductive reasoning in healthy young adolescents after a daily intake of peanuts.

    To measure in attention and inductive reasoning, the Raven-2 test will be used.

    Baseline and after 6 months

  • Changes in Social cognition (emotion recognition and theory of mind) in healthy young adolescents after a daily intake of peanuts.

    To measure Social cognition (emotion recognition and theory of mind), the NEPSY-II subtest will be used.

    Baseline and after 6 months

  • Changes in pro- and anti-inflammatory biomarkers after a daily intake of peanuts in healthy young adolescents.

    Cytokines (pg/mL), Monocyte chemoattractant protein-1 (MCP-1) (pg/mL), interleukin (IL)-6 and 10 (pg/mL), (mg/dL) will be assayed by immunoenzymatic methods.

    Baseline and after 6 months

  • Changes in vascular biomarkers after a daily intake of peanuts in healthy young adolescents.

    sVCAM-1 and sICAM-1 (ug/mL) will be assayed by immunoenzymatic methods.

    Baseline and after 6 months

  • Changes in adiposity molecules after a daily intake of peanuts in healthy young adolescents

    Adiponectin and adipsin (ug/mL), leptin (pg/mL), ghrelin (pg/mL), visfatin (pg/dL), resistin (pg/mL), insulin (pg/mL), glucagon (pg/dL), peptid C (pg/mL) and, PAI-1 (pg/mL) will be assayed by immunoenzymatic methods.

    Baseline and after 6 months

  • Changes in body mass index after a daily intake of peanuts in healthy young adolescents

    Body mass index (kg/m\^2) are calculated after measure weight (kg) and height (meter).

    Baseline, 3 and after 6 months

Secondary Outcomes (13)

  • Changes in waist circumference after a daily intake of peanuts in healthy young adolescents

    Baseline, 3 and after 6 months

  • Changes in blood pressure after a daily intake of peanuts in healthy young adolescents

    Baseline, 3 and after 6 months

  • Changes in heart rate after a daily intake of peanuts in healthy young adolescents

    Baseline, 3 and after 6 months

  • Changes in lipidic profile after a daily intake of peanuts in healthy young adolescents

    Baseline and after 6 months

  • Changes in blood glucose after a daily intake of peanuts in healthy young adolescents

    Baseline and after 6 months

  • +8 more secondary outcomes

Study Arms (2)

Peanuty group

EXPERIMENTAL

Families allocated in the intervention group will receive the whole skin roasted peanuts packed in daily doses (25 g per day, 750 g per month), starting the day that we will visit the participants for the first time. They will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.

Other: Food (peanut)

Control group

NO INTERVENTION

Usual care

Interventions

After the recruitment, the participants will follow a peanut-free diet for two weeks.

Peanuty group

Eligibility Criteria

Age10 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Eligible participants will be young adolescents, boys and girls, aged between 10 and 12 years who attend regular primary schools in Barcelona. The schools will assist with the participant recruitment through the classes and after that, a total of one-hundred students will be randomly included in each group. In all cases, participation will be voluntary and informed consent will be obtained prior to the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IDIBAPS

Barcelona, Barcelona, 08036, Spain

RECRUITING

MeSH Terms

Conditions

InflammationBody Weight ChangesBody WeightObesityMotor Activity

Interventions

Food

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Diet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A multi-school, two-arm parallel cluster-randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 31, 2023

First Posted

November 13, 2023

Study Start

January 29, 2024

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

The dataset analyzed during the current study is not publicly available due to national data regulations and for ethical reasons, e.g. we do not have the explicit written consent of the study volunteers to make their deidentified data available at the end of the study. However, data described in the manuscript, codebook, and analytic codes will be made available upon request by contacting the PI and Co-PI (peanuty2023@gmail.com). The request will be passed to all the members of the study for deliberation.

Locations